Becton Dickinson (BDX)Officer sold ~$11K

~$11K

Approx. value · 74 sh @ $151.94

21K

Holds after · shares reported

Traded

Apr 27, 2026

Filed

Apr 28, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Oct 9, 2025Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On October 15, 2025, the Company filed a Current Report on Form 8-K that reported that Vitor Roque, who previously served as the Company’s Senior Vice President of Finance, Business Units and Corporate Financial Planning & Analysis, was appointed as the Company’s interim Chief Financial Officer, effective December 5, 2025.”
2. Feb 26, 2026InsiderOfficer sold ~$14K of BDX shares in the open market
3. Mar 17, 2026CongressDisclosed sale of BDX — reported range $15,001 - $50,000
4. Mar 26, 20265% stakeThe Vanguard Group reported a passive stake (13G)
5. Mar 26, 2026InsiderOfficer sold ~$12K of BDX shares in the open market
6. Mar 27, 2026CongressDisclosed purchase of BDX — reported range $1,001 - $15,000
7. Apr 2, 2026Company filing · Form 8-K · ResultsReported its results
8. Apr 6, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On April 6, 2026, Richard E. Byrd, Executive Vice President and President of the Interventional segment of Becton, Dickinson and Company (“BD”), informed BD of his intention to retire.”
9. Apr 27, 2026 · this disclosureInsiderOfficer sold ~$11K of BDX shares in the open market

What came next

1. Apr 28, 2026Company filing · Form 8-K · Bylaws or charterChanged its bylaws, charter or fiscal year
2. Apr 29, 20265% stakeVanguard Portfolio Management reported a passive stake (13G) of 5.4%
3. Apr 29, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.5%
4. May 7, 2026Company filing · Form 8-K · ResultsReported its results
5. May 15, 20265% stakeT. Rowe Price Investment Management, Inc. reported a passive stake (13G) of 3.4%
6. May 20, 2026Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations
7. May 21, 2026CongressDisclosed sale of BDX — reported range $1,001 - $15,000
8. May 26, 2026InsiderOfficer sold ~$11K of BDX shares in the open market
9. Jun 1, 2026InsiderCEO sold ~$405K of BDX shares in the open market
10. Jun 10, 2026InsiderOfficer sold ~$167K of BDX shares in the open market
11. Jun 11, 2026FDARecall: BD ChloraPrep Hi-Lite Orange, (2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol (IPA)), packaged as a) 100 x 10.5 mL applicators/case, NDC 54…
12. Jun 11, 2026FDARecall: ChloraPrep FREPP, Clear, (2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol) 500 x 1.5 mL applicators/case, STERILE SOLUTION, CareFusion 123,…
13. Jun 24, 2026InsiderOfficer sold ~$160K of BDX shares in the open market
14. Jun 25, 2026FDARecall: Products that contain the Pericare Wipes: SureStep" Foley Tray System Add-A-Foley Catheter REF: A153200 UDI code: 00801741121067¿ 10801741121064 SureStep" Fole…
15. Jun 25, 2026FDARecall: Products that contain the Pericare Wipes: Bard¿ Foley Tray With Lubri-Sil¿ All-Silicone Foley Catheter REF: 947314 947316 947318 UDI codes: 00801741024924¿ 108…
16. Jun 25, 2026FDARecall: Products that contain the Pericare Wipes: Bardex Lubricath Foley Catheter Tray REF: 899914 899916 899918 UDI codes: 00801741024801¿ 10801741024808 008017410248…
17. Jun 25, 2026FDARecall: Products that contain the Pericare Wipes: (Canada Only) SureStep" Foley Tray System Bardex¿ IC Complete Care¿ REF: A300314AC UDI-DI code: 00801741143243 SureSt…
18. Jun 25, 2026FDARecall: Products that contain the Pericare Wipes: SureStep Intermittent Catheter Tray REF: INTP16 INTS14 INTS14C INTS16 INTS16C PEDINTS06 PEDINTS08 PEDINTS10 UDI code:…
19. Jun 25, 2026FDARecall: Products that contain the Pericare Wipes: *Bardex¿ I.C. Complete Care¿ Foley Catheter Tray REF: 300316A UDI codes: 00801741024344¿ 10801741024341 *Bardex¿ I.C.…
20. Jun 26, 2026InsiderOfficer sold ~$11K of BDX shares in the open market

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Becton Dickinson

For Becton Dickinson, OQRO holds 6 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 28 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BDX page.

Other recent filings by Michael Feld, EVP, Chief Revenue Officer

• SEC Form 4 at Becton Dickinson (BDX)Sep 30, 2026
• SEC Form 4 at Becton Dickinson (BDX)Aug 27, 2026
• SEC Form 4 at Becton Dickinson (BDX)Jul 28, 2026
• SEC Form 4 at Becton Dickinson (BDX)Jun 27, 2026
• SEC Form 4 at Becton Dickinson (BDX)May 27, 2026

The full history of Michael Feld, EVP, Chief Revenue Officer is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Becton Dickinson

• SEC Form 4Sep 30, 2026
• SEC Form 144Sep 28, 2026
• SEC Form 4Aug 27, 2026
• SEC Form 13F-HRAug 18, 2026
• SEC Form 4Aug 14, 2026
• SEC Form 13F-HRAug 14, 2026

Everything OQRO holds on this company is on its BDX page.